Cargando…
HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin
Small molecules that bind to allosteric sites on target proteins to alter protein function are highly sought in drug discovery. High-throughput screening (HTS) assays are needed to facilitate the direct discovery of allosterically active compounds. We have developed technology for high-throughput ti...
Autores principales: | Muretta, JM, Rajasekaran, D, Blat, Y, Little, S, Myers, M, Nair, C, Burdekin, B, Yuen, SL, Jimenez, N, Guhathakurta, P, Wilson, A, Thompson, AR, Surti, N, Connors, D, Chase, P, Harden, D, Barbieri, CM, Adam, L, Thomas, DD |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422832/ https://www.ncbi.nlm.nih.gov/pubmed/37307989 http://dx.doi.org/10.1016/j.slasd.2023.06.001 |
Ejemplares similares
-
Direct detection of the myosin super-relaxed state and interacting-heads motif in solution
por: Chu, Sami, et al.
Publicado: (2021) -
Actin-Myosin Interaction: Structure, Function and Drug Discovery
por: Guhathakurta, Piyali, et al.
Publicado: (2018) -
Cardiac myosin-binding protein C interaction with actin is inhibited by compounds identified in a high-throughput fluorescence lifetime screen
por: Bunch, Thomas A., et al.
Publicado: (2021) -
FLIM-FRET analyzer: open source software for automation of lifetime-based FRET analysis
por: Kim, Jiho, et al.
Publicado: (2017) -
in vivo quantitative FRET small animal imaging: intensity versus lifetime-based FRET
por: Smith, Jason T., et al.
Publicado: (2023)